Expands drug manufacturer annual reporting requirements to include all patient assistance programs offered or funded by the manufacturer that provided assistance to consumers in this state in the previous calendar year. Becomes operative on January 1, 2028.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.
4
More on this bill
Where it stands
Introduced
Passed Senate
3Passed House
4To Governor
5Became Law
Looking ahead
No hearings or votes scheduled.
History
2026
Mar 7In committee upon adjournment.Latest
Mar 2Public Hearing held.
Feb 25Referred to Rules.Minor
Vote recorded Third reading. Carried by Patterson. Passed. Result: pass.Upper
Feb 25First reading. Referred to Speaker's desk.Minor
Feb 25Third reading. Carried by Patterson. Passed.Passed Senate
Feb 23Second reading.Minor
Feb 20Recommendation: Do pass with amendments. (Printed A-Eng.)Minor
Feb 16Work Session held.
Vote recorded Heard and Reported Out with Amendments. Result: pass.Upper
Feb 11Public Hearing held.
Feb 2Referred to Health Care.Minor
Feb 2Introduction and first reading. Referred to President's desk.Introduced